Supreme Court to Consider Overturning FDA Approval of Abortion Pill

The decision could have far-reaching implications for the FDA's regulatory authority and the future of medical innovation.

Republican presidential candidate Vivek Ramaswamy said he hopes the U.S. Supreme Court will overturn the FDA's approval of the abortion pill, arguing the agency exceeded its authority by approving mifepristone in 2000.
The Supreme Court agreed to consider appeals from the Biden administration and drug manufacturer Danco defending several actions by the FDA intended to make it easier to access and use mifepristone.
Pro-life doctors, represented by the Alliance Defending Freedom, have challenged FDA approval of mifepristone on the grounds that the agency inappropriately expedited the drug's approval.
The case could have implications for the regulatory authority of the FDA, which approved the pill more than two decades ago.
The Supreme Court is expected to issue a decision by the end of its term, in late June, during the campaign season.